Literature DB >> 2044761

Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle.

K Ohlendieck1, K P Campbell.   

Abstract

Dystrophin, which is absent in skeletal muscle of Duchenne muscular dystrophy patients, has not been considered to play a major structural role in the cell membrane of skeletal muscle because of its low abundance (approximately 0.002% of total muscle protein). Here, we have determined the relative abundance of dystrophin in a membrane cytoskeleton preparation and found that dystrophin constitutes approximately 5% of the total membrane cytoskeleton fraction of skeletal muscle sarcolemma. In addition, dystrophin can be removed from sarcolemma by alkaline treatment. Thus, our results have demonstrated that dystrophin is a major component of the subsarcolemmal cytoskeleton in skeletal muscle and suggest that dystrophin could play a major structural role in the cell membrane of skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044761     DOI: 10.1016/0014-5793(91)80595-t

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 2.  Proteomic profiling of x-linked muscular dystrophy.

Authors:  Caroline Lewis; Steven Carberry; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2009-12       Impact factor: 2.698

3.  Dystrophin-glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling.

Authors:  Joanne F Garbincius; Daniel E Michele
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

4.  Size and localization of dystrophin molecule: immunoelectron microscopic and freeze etching studies of muscle plasma membranes of murine skeletal myofibers.

Authors:  Y Wakayama; S Shibuya; T Jimi; A Takeda; H Oniki
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors:  K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

Review 6.  Aquaporin expression in normal and pathological skeletal muscles: a brief review with focus on AQP4.

Authors:  Yoshihiro Wakayama
Journal:  J Biomed Biotechnol       Date:  2010-03-21

7.  Dystrophin is phosphorylated by endogenous protein kinases.

Authors:  M Luise; C Presotto; L Senter; R Betto; S Ceoldo; S Furlan; S Salvatori; R A Sabbadini; G Salviati
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

8.  Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.

Authors:  Paul Dowling; Philip Doran; Kay Ohlendieck
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

9.  Isolation and characterization of different C-terminal fragments of dystrophin expressed in Escherichia coli.

Authors:  R E Milner; J Busaan; M Michalak
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.

Authors:  K Matsumura; F M Tomé; V Ionasescu; J M Ervasti; R D Anderson; N B Romero; D Simon; D Récan; J C Kaplan; M Fardeau
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.